SPL 0.00% 9.2¢ starpharma holdings limited

Ann: DEP irinotecan clinical data presented at AACR meeting, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. bid
    688 Posts.
    lightbulb Created with Sketch. 176
    Proof of concept first in entirety should see significant sp rise then negotiate deals from strength. To achieve maximum shareholder value is what I said. And that’s counter intuitive because?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.